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RHEIN, THE METABOLITE OF DIACERHEIN,
MODULATES PROLIFERATION OF ARTICULAR
CHONDROCYTES AND SYNOVIOCYTES
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H. Ficheux3
1Faculty of Medicine, Caen, France, 2Clinic Saint-Martin, Caen,
France, 3NEGMA-LERADS Laboratories, 78771
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Purpose: To determine the effects of pharmacologically relevant
concentrations of Rhein, the metabolite of Diacerhein, on cell
proliferation rate of both human chondrocytes and synoviocytes.
Methods: Human articular chondrocytes and synoviocytes were
obtained from the knee or hankle of osteoarthritic patients. They
were isolated by enzymatic procedure and cultured as monolay-
ers in DMEM + 10% FCS, either in normal atmosphere (21% O2
for synoviocytes) or in hypoxia (5% O2 for chondrocytes), with
10-6, 10-5, and 10-4M Rhein or the corresponding concentrations
of its vehicle DMSO. [3H] thymidine incorporation was used to
determine Rhein proliferative effects at 24 h, 48 h and one week
incubation times. Cytotoxicity of the drug was also assayed with
a non radioactive assay kit. Nuclear extracts were prepared and
used to detect variation of cell cycle proteins by Western blotting.
Moreover, Rhein effects on apoptosis were investigated through
measurement of caspase activity.
Results: Rhein inhibited the proliferation rate of both chon-
drocytes and synoviocytes in a dose-dependent manner, with
significant decrease of thymidine labeling for 10-5 M Rhein (by
approximately two-fold) and for 10-4 M Rhein (around 5-6 fold).
In the same experimental conditions, no cytotoxicity of the drug
was observed as compared to its vehicle DMSO. Western blots
showed that Rhein modulates expression of cell cycle proteins:
Rhein at 10-4 M decreased p27 expression, but not that p21, nor
cyclin D1 expression.
Conclusions: Previous results indicated that Rhein may reduce
the IL-1β deleterious effects on osteoarthritis cartilage through
inhibition of the expression of degrading enzymes. Here we
showed that Rhein could inhibit proliferation of both synoviocytes
and chondrocytes. Thus, by its antiproliferative properties, this
drug may decrease the development of the inflammatory synovial
tissue that accompanies both OA and RA joint pathologies. Both
its anti-catabolic and anti-proliferative effects may explain its
value for the treatment of joint diseases.
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GLUCOSAMINE REDUCES CATABOLIC AND ANABOLIC
PROCESSES IN CHONDROCYTES; INDICATIONS FOR
INTERFERENCE WITH INTRACELLULAR ENERGY
MANAGEMENT
E.J. Uitterlinden, H. Jahr, J.L. Koevoet, S.M. Bierma-Zeinstra,
J.A. Verhaar, H. Weinans, G.J. van Osch
Erasmus MC, University Medical Center, Rotterdam, The
Netherlands
Purpose: Glucosamine (GlcN) is increasingly being used for its
claimed structure modifying effects in osteoarthritis. Despite this,
the debate on its exact mechanism of action still continues. In
vitro studies have reported conflicting results, probably due to
different culture conditions in these various studies. The aim of
our study was to determine the effects of GlcN under anabolic
and catabolic culture conditions.
Methods: Chondrocytes from 6-12 month old calf MCP joints
were seeded in alginate beads and cultured in low glucose D-
MEM with 10% FCS and 25 μg/ml ascorbic acid 2-phosphate. To
evaluate the effect under anabolic conditions 5 mM glucosamine
hydrochloride (GlcN-HCl) or N-acetyl-glucosamine (N-Ac-GlcN)
were added to the cultures for 14 days after a 3-day pre-culture
period. For the evaluation of the effect of GlcN under catabolic
conditions, alginate beads were treated with 10 ng/ml recombi-
nant human IL-1β on day 8-10, in combination with GlcN-HCl 5
mM from day 6-10. Following this treatment, culturing was con-
tinued for 7 more days. A no supplement condition and GlcN-HCl
pre-treatment only condition were used as controls. Beads were
harvested for analyses of DNA and GAG content at various time
points.
Results: The no supplements control and 5 mM N-Ac-GlcN
showed an increase of GAG content with time during the first 17
days of culture. Addition of 5 mM GlcN-HCl showed a statistically
significant reduced GAG production. The amount of DNA per
bead showed a similar trend.
As expected, addition of IL-1β also led to inhibition of GAG
content. Pre-treatment with GlcN-HCl, reduced the effect of IL-
1β.
Conclusions: This study indicates that GlcN-HCl inhibits an-
abolic and the catabolic process. A possible explanation might
be a direct competition between glucose and GlcN-HCl. At first on
entering the cell, utilizing the same transporter system and sec-
ondly intracellular, since glucose and GlcN are both phosphory-
lated by glucokinase. Phosphorylated GlcN in turn is an allosteric
inhibitor of glucokinase, resulting in extra negative feedback. The
result of this competition might be that less glucose-6-P en-
ters the glycolysis, leading to a depletion of intracellular ATP.
This eventually results in less energy for all kinds of intracellular
processes, like extracellular matrix production and breakdown.
This competition hypothesis was tested by adding more glucose
to the medium and that resulted in normalization of GAG syn-
thesis. An explanation why N-Ac-GlcN does not inhibit matrix
synthesis, may be that it is phosphorylated by a different enzyme
and thus no competition with glucose occurs, while the phospho-
rylated product can be used for GAG synthesis as well. Based
on our results, we propose that the claimed structure modifying
effects of glucosamine might be based on interference with the
energy household of chondrocytes.
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Purpose: To determine the best protocol for the preparation of
a tissue-engineered cartilage to investigate the potential anti-
arthritic and/or anti-osteoarthritic effects of drugs such as Avo-
cado/Soybean Unsaponifiables (ASU).
Methods: Calf articular chondrocytes, seeded in collagen
sponges, were grown in culture for up to 1 month. Cultures
received interleukin (IL)-1b (ranging from 0.1 to 20 ng/ml) at day
14 for 1 to 3 days and/or ASU (ranging from 1 to 10 ug/ml) from
day 2 every day or from day 14 for 1 to 3 days. Analyses of gene
expression for extracellular matrix proteins, collagen-binding inte-
grins, matrix metalloproteinases (MMPs), aggrecanases, TIMPs,
IL-1Ra and Ik-Ba were carried out using real-time polymerase
chain reaction (PCR). Metalloproteinase activities were analysed
in the culture medium using both zymography and fluorogenic
peptide substrates.
Results: We selected a culture for 15 to 18 days with collagen
sponges seeded with 107 chondrocytes showing a minimal cell
proliferation, a maximal sulphated glycosaminoglycan (sGAG)
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deposition and a high expression of COL2A1, aggrecan and the
a10 integrin sub-unit and low expression of COL1A2 and the a11
integrin sub-unit. After treatment at day 14 with 1 ng/ml IL-1b, we
observed at day 15 up-regulations of 450-fold for MMP-1, 60-fold
for MMP-13, 54-fold for ADAMTS-4 and MMP-3 and 10-fold for
ADAMTS-5 and IL-1Ra. Down-regulations of 2.5-fold for COL2A1
and aggrecan were observed only at day 17. At the protein level
a dose-dependent increase of total MMP-1 and MMP-13 was
noted with less than 15% in the active form. The effect of a 1 day
treatment with 1 ng/ml Il-1b (day14/15) disappears completely
after 3 days (day 18).
In this culture model, in the absence of IL-1b, addition of ASU
was without effect on the chondrocyte metabolism. However,
treatment with ASU (10 ug/ml) from day 14 decreased signifi-
cantly at day 16 the level of expression of MMP-3 and MMP-13
activated by a 1 day treatment (day 14/15) with 1 ng/ml IL-1b.
Conclusions: This in vitro model of chondrocyte culture in three
dimensional (3D) seems well adapted to investigate the re-
sponses of these cells to inflammatory cytokines and to evaluate
the potential anti-inflammatory effects of drugs. Under the con-
ditions selected, chondrocytes maintained a cartilage phenotype
and expressed a catabolic profile when stimulated by IL-1b. ASU
were able to partially counteract this effect demonstrating their
potential to reduce the deleterious effect of IL-1 reported in OA.
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EXPOSURE OF HUMAN CARTILAGE TISSUE TO LOW
CONCENTRATIONS OF BLOOD FOR A SHORT PERIOD
OF TIME LEADS TO PROLONGED CARTILAGE DAMAGE;
AN IN VITRO STUDY
N.W. Jansen1, G. Roosendaal1, J.W. Bijlsma1, J. DeGroot2,
F.P. Lafeber1
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Purpose: Exposure of cartilage to blood as a consequence of
joint bleeds leads to cartilage damage. In the present study we
determined the thresholds for the exposure time and concentra-
tion that lead to prolonged cartilage damage caused by exposure
of cartilage to blood. This information may be particularly useful
in the discussion whether aspiration of blood from a joint after a
haemarthros is indicated or not.
Methods: Healthy human articular cartilage tissue explants were
cultured in the presence or absence of 50% v/v blood for 1, 2,
3 or 4 days or for four days in the presence of 0, 5, 10, 20,
30 or 50% v/v blood, both followed by a recovery period of 12
days. The effect of blood exposure on cartilage was determined
by measuring matrix synthesis, release, and content, as well as
MMP-activity.
Results: Exposure of cartilage to 50% v/v blood led to direct
cartilage damage largely independent of the exposure time; a
complete inhibition of matrix synthesis, an approximate doubling
of the release, and increased MMP activity and a decreased
proteoglycan content were observed. These effects persisted
during recovery in the absence of blood but only after an initial
exposure equal to or exceeding 2 days. Exposure of cartilage for
4 days to varying doses of blood led to concentration dependent
cartilage damage. These effects were long lasting when the
concentration equalled or exceeded 10% v/v blood. When a
blood load of 10% v/v for 2 days was evaluated, the adverse
effects on cartilage were also persisting. All data are statistically
significant.
Conclusions: This study demonstrates that a 2-day exposure of
cartilage to 10% v/v blood (in vitro) leads to prolonged impairment
of joint cartilage. This suggests that aspiration of blood from a
joint within 2 days should be considered in clinical practice to
prevent blood induced joint damage.
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DEGENERATED CARTILAGE IS SLIGHTLY MORE PRONE
TO BLOOD INDUCED CARTILAGE DAMAGE
N.W. Jansen, G. Roosendaal, J.W. Bijlsma, F.P. Lafeber
UMC Utrecht, Utrecht, The Netherlands
Purpose: Joint bleeds can occur after a joint trauma and are
frequently seen in patients suffering from haemophilia. Even a
limited number of these joint bleeds lead to severe joint de-
struction in later years. Currently the general opinion amongst
physicians is that a few joint bleeds are acceptable. However,
it could well be that degenerated cartilage that is impaired by
previous joint bleeds or mechanical stress (e.g. osteoarthritic
cartilage) is more susceptible to blood induced damage. When
this holds true, this would implicate that specifically in case
of degenerated cartilage, joint bleeds should be prevented to
avoid joint destruction in later years. We therefore investigated
whether degenerative and osteoarthritic cartilage are more sus-
ceptible to blood induced cartilage damage than healthy carti-
lage.
Methods: Healthy, degenerative and osteoarthritic human ar-
ticular cartilage tissue explants were cultured in the presence
or absence of 10% v/v blood for 2 days (a minimal blood load
compared to a clinical joint haemorrhage), followed by a recov-
ery period of 12 days. The effect of blood exposure to cartilage
was determined by its effect on matrix synthesis, release, and
content. Both the direct effects and the effects after the recovery
period were determined.
Results: When healthy cartilage was exposed to blood, this re-
sulted in a direct decrease of the matrix synthesis (-73%), and
an increase in release of matrix components (+148%). These ef-
fects were still present after the recovery period and at that time
proteoglycan content of the matrix was decreased (-18%). The
degenerative and osteoarthritic cartilage had the characteristic
decreased synthesis, increased release, and decreased content
of proteoglycans. Release of proteoglycans after the recovery
period was slightly but statistically significantly elevated for the
degenerated cartilage compared to healthy cartilage (p<0.05).
The other parameters were not significantly changed in degen-
erated cartilage compared to healthy cartilage.
Conclusions: This study demonstrates that degenerated and
osteoarthritic cartilage are slightly more susceptible to the ad-
verse effects of blood exposure than healthy cartilage. It might
therefore be of importance to prevent joint bleeds in patients
with degenerated cartilage due to e.g. osteoarthritis. Moreover,
aspiration of blood in case of a joint haemorrhage is indicated
under these conditions.
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Purpose: Osteochondritis dissecans (OCD) is a common dis-
ease with unknown aetiology which particularly affects young
people. It is characterized by a separation of a cartilage frag-
ment with the subchondral bone. Many hypotheses about its
aetiopathogenesis have been proposed, one of the most con-
siderable, the start of a catabolic program following an initial
traumatic event. The aim of the study was to highlight these
mechanisms and to look for an apoptosis activity as one of a
probable cause of the pathology development.
